The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Majoven XL 75 mg prolonged-release capsules, hard

Brillpharma (Ireland) LimitedPA22749/014/002

Main Information

Trade NameMajoven XL 75 mg prolonged-release capsules, hard
Active SubstancesVenlafaxine
Dosage FormProlonged-release capsule, hard
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/014/002

Group Information

ATC CodeN06AX Other antidepressants
N06AX16 venlafaxine


License statusAuthorised
Licence Issued27/01/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licencemedicinal product subject to restricted prescription
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0026-028-030
Interchangeable List DocumentPDF of Interchangeable List
« Back